| Field | Specification |
|---|---|
| Target | |
| Alternative names | Beclin-1;Coiled-coil myosin-like BCL2-interacting protein;Protein GT197;BECN1;GT197; |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | E.coli-derived human Beclin 1 recombinant protein (Position: M1-S354). Human Beclin 1 shares 97% amino acid (aa) sequence identity with both mouse and rat Beclin 1. |
| Molecular weight | |
| Purification | |
| Reconstitution | |
| Cellular localization | |
| Concentration | |
| Form | Lyophilized |
| Storage | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
This rabbit polyclonal antibody recognizes beclin-1 (gene BECN1) in human, mouse and rat samples and is validated for Western blot, ICC/IF, flow cytometry and immunoprecipitation. The predicted molecular weight is 51.9 kDa, and the supplier reports an observed band at about 60 kDa.
Beclin-1 (BECN1) is a core subunit of the class III phosphatidylinositol 3-kinase (VPS34) complex, which generates phosphatidylinositol 3-phosphate to start autophagosome formation. It also functions in endocytic trafficking, and its activity is controlled by binding partners such as Bcl-2. Beclin-1 is a widely used marker in autophagy research.
| Target | Beclin-1 (gene BECN1; UniProt Q14457, human) |
|---|---|
| Host / Clonality / Isotype | Rabbit / Polyclonal / Rabbit IgG |
| Reactivity | Human, Mouse, Rat |
| Form | Lyophilized |
| Formulation | Per vial: 4 mg trehalose; 0.9 mg NaCl; 0.2 mg Na2HPO4 |
| Calculated MW | 51.9 kDa |
| Observed MW | 60 kDa |
| Storage | As supplied: −20 °C for up to 12 months from receipt. After reconstitution: 4 °C for up to 1 month, or aliquot and keep at −20 °C for up to 6 months. Avoid repeated freeze–thaw cycles. |
Validated Applications
| Western blot | 0.1–0.5 µg/mL (Human, Mouse, Rat) |
|---|---|
| Immunocytochemistry / Immunofluorescence | 5 µg/mL (Human) |
| Immunoprecipitation | 0.5–2 µg/mL (Human) |
| Flow cytometry (fixed cells) | 1–3 µg/1×106 cells (Human) |
Samples with a confirmed band (WB): human Raji cells lysate, human 293T cells lysate, human MCF-7 cells lysate, human PC-3 cells lysate, rat C6 cells lysate, rat PC-12 cells lysate, mouse NIH/3T3 cells lysate, mouse RAW264.7 cells lysate.
Recommended loading (WB): 20–40 µg of total protein per lane.
Conditions in the example images (WB): 5–20% gradient SDS-PAGE under reducing conditions, 30 µg lysate per lane, transfer to nitrocellulose membrane, blocking in 5% non-fat milk, primary antibody at 0.5 µg/mL overnight at 4 °C, HRP-conjugated secondary antibody at 1:5000, ECL detection.
Samples with confirmed staining (ICC/IF): HeLa cells.
Samples with a confirmed signal (flow cytometry): Raji cells.
Samples with a confirmed result (IP): MCF-7 cells.
Immunogen
Recombinant human Beclin 1 fragment (Met1–Ser354), expressed in E. coli. Sequence identity with the mouse and rat orthologs: 97%.
Reactivity Notes
The supplier lists reactivity with human, mouse and rat. UniProt places beclin-1 in the cytoplasm, endosome membrane, endoplasmic reticulum membrane and mitochondrion membrane. Tissue expression noted by UniProt (human): Ubiquitous. The samples tested by the supplier (listed above) are a practical starting point for positive controls.
Safety
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
Xiao Weiping et al. (2025) Exercise-induced irisin ameliorates cognitive impairment following chronic cerebral hypoperfusion by suppressing neuroinflammation and hippocampal neuronal apoptosis. Journal of Neuroinflammation. 10.1186/s12974-025-03493-5
Yu-Yuan Peng et al. (2025) Deletion of p75NTR rescues behavioral and cognitive dysfunction in SPS-induced PTSD mice through hippocampal PI3K/Akt/mTOR pathway. International Journal of Biological Macromolecules. 10.1016/j.ijbiomac.2025.142770
Gang Zhong et al. (2019) Dopamine-melanin nanoparticles scavenge reactive oxygen and nitrogen species and activate autophagy for osteoarthritis therapy. Nanoscale. 10.1039/C9NR03060C
Zhiwei Liao et al. (2021) Autophagic Degradation of Gasdermin D Protects against Nucleus Pulposus Cell Pyroptosis and Retards Intervertebral Disc Degeneration In Vivo. Oxidative Medicine and Cellular Longevity. 10.1155/2021/5584447
Luo Haotian et al. (2024) Lhx6 deficiency causes human embryonic palatal mesenchymal cell mitophagy dysfunction in cleft palate. Molecular Medicine. 10.1186/s10020-024-00960-2
Ya Chen et al. (2023) ACKR4a induces autophagy to block NF-κB signaling and apoptosis to facilitate Vibrio harveyi infection. iScience. 10.1016/j.isci.2023.106105
Li Haoyuan et al. (2019) Melatonin Enhances Proliferation and Modulates Differentiation of Neural Stem Cells Via Autophagy in Hyperglycemia. Stem Cells. 10.1002/stem.2968
Qian Shi et al. (2023) LncRNA THRIL, transcriptionally activated by AP-1 and stabilized by METTL14-mediated m6A modification, accelerates LPS-evoked acute injury in alveolar epithelial cells. International Immunopharmacology. 10.1016/j.intimp.2023.110740
Yaqian Xu et al. (2023) Buyang Huanwu Decoction alleviates cerebral ischemic injury through modulating caveolin-1-mediated mitochondrial quality control. Frontiers in Pharmacology. 10.3389/fphar.2023.1137609
Ya Chen et al. (2022) eIF3k inhibits NF-κB signaling by targeting MyD88 for ATG5-mediated autophagic degradation in teleost fish. Journal of Biological Chemistry. 10.1016/j.jbc.2022.101730
